Speedy recovery: Low-Dose sedative gets breast cancer patients home in under 2 hours

NCT ID NCT07180810

Completed Symptom relief Sponsor: Shaukat Khanum Memorial Cancer Hospital & Research Centre Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a low dose of the sedative dexmedetomidine could help women leave the hospital sooner after day-case breast cancer surgery. 82 women were randomly assigned to receive either the drug or a placebo during surgery. The main goal was to see how many could be discharged within 2 hours. The results could point to a simple way to speed up recovery and improve comfort after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dexmedetomidine
What this could lead to: If it works, this could help women recover faster and go home sooner after breast cancer surgery, reducing hospital stays.
What could go wrong: This is a small, completed trial with 82 participants. The drug may cause side effects like low heart rate or drowsiness, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST ANESTHESIA DISCHARGE TIME IN PATIENTS OF BREAST CANCER SURGERY

Contacts and locations

Locations

Shaukat Khanum Memorial Cancer Hospital and Research Centre

Lahore, Pubjab, 54782, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.